歡迎光臨源葉生物,登錄 | 注冊(cè) |
當(dāng)前位置: 首頁(yè) > 小分子抑制劑 > Endocrinology/Hormones > AZD3514

瀏覽歷史

S80214

AZD3514

源葉(MedMol) ≥98%
  • 英文名:
  • AZD3514
  • 別名:
  • S7040,AZD 3514; 6-(4-{4-[2-(4-acetylpiperazin-1-yl)ethoxy]phenyl}piperidin-1-yl)-3-(trifluoromethyl)-7,8-dihydro[1,2,4]triazolo[4,3-b]pyridazine; 1-(4-(2-(4-(1-(3-(trifluoromethyl)-7,8-dihydro-[1,2,4]
  • CAS號(hào):
  • 1240299-33-5
  • 分子式:
  • C25H32F3N7O2
  • 分子量:
  • 519.56
品牌貨號(hào)產(chǎn)品規(guī)格價(jià)格(RMB) 庫(kù)存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購(gòu)物車(chē)...
源葉(MedMol) S80214-5mg ≥98% ¥610.00元 10 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S80214-25mg ≥98% ¥2060.00元 9 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S80214-100mg ≥98% ¥5150.00元 3 - - - EA 加入購(gòu)物車(chē)
大包裝詢(xún)價(jià)

提交您的電話(huà)號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)

質(zhì)檢證書(shū)(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 提示:詳情請(qǐng)下載說(shuō)明書(shū)。
  • 產(chǎn)品描述: AZD3514 is an orally activie and selective androgen receptor (AR) inhibitor. AZD3514 androgen-dependently and -independently inhibits AR signal. AZD351 down-regulates nuclear AR levels in human LNCaP prostate cancer cells in the absence of androgen with an pIC50 value of 5.75. AZD3514 can be used for the research of prostate cancer
  • 靶點(diǎn): Androgen Receptor;AndrogenReceptor
  • 體內(nèi)研究:
    AZD3514 (10-100 mg/kg; p.o. once daily for 6 days) inhibits AR signaling in rats. AZD3514 (50 mg/kg; p.o. once daily for 30 days) inhibits prostate tumor growth. AZD3514 (50-100 mg/kg; p.o. once daily for 3 days) significantly reduces nuclear AR protein in vivo
  • 參考文獻(xiàn):
    1. Bradbury RH, et al. Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancer. Bioorg Med Chem Lett. 2013 Apr 1;23(7):1945-8. 2. Loddick SA, et al. AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivo. Mol Cancer Ther. 2013 Sep;12(9):1715-27. 3. Omlin A, et al. AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies. Invest New Drugs. 2015 Jun;33(3):679-90.
  • 溶解性: Soluble  in  DMSO
  • 保存條件: -20°C
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 1.925 ml 9.624 ml 19.247 ml
    5 mM 0.385 ml 1.925 ml 3.849 ml
    10 mM 0.192 ml 0.962 ml 1.925 ml
    50 mM 0.038 ml 0.192 ml 0.385 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶(hù)參考交流研究之用。
輸入產(chǎn)品批號(hào):

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷(xiāo)售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷(xiāo)售條款。